Inside Innovation

The Bill & Melinda Gates Foundation and the Ballmer family have gifted UW Medicine $20 million in honor of former dean, Dr. Paul Ramsey. The

A new report from WalletHub ranks Seattle as the best overall metro area for STEM professionals in the U.S. The rankings were determined based on

After analyzing over 200,000 human stem cells in 3D high resolution, researchers at Seattle’s Allen Institute for Cell Science and their colleagues developed an approach

The Seattle Inno and the Puget Sound Business Journal recently announced the 23 startups to watch in 2023. The list was compiled by account factors such as revenue growth,

In an exclusive interview with Investment Reports, Marc Cummings, President and CEO of Life Science Washington, shared details on the state of the life science

The Kirkland-based company, Cardiac Dimensions, announced a $35 million Series D round with plans to grow its team and advance through U.S. clinical trials for

Following a positive release of clinical data from a phase 2b testing trial of zanidatamab, Zymeworks, based in the Pacific Northwest, has secured $350 million

Seattle-based biotech, Kineta Inc., recently completed a reverse merger with biotech Yumanity Therapeutics. Along with the merger, Kineta closed a $7.5 million private investment in

ActX, a biotech company based in Seattle, has raised $6 million in equity funding and is seeking an additional $107,000 to further its work in

Data from the 2019 U.S. Census Bureau reveals that while women make up over half of the workforce in the country, they only make up

Fred Hutch Cancer Center received an additional $1 million from the Washington Research Foundation (WRF). The grant will aid in the collaborative funding program for the advancement

BioSpace recently revealed its NextGen Bio Class of 2023, which features top life science startups in North America. The top companies were evaluated based on